Pancreatic cancer symptoms: A sign when you go to the toilet of the 'silent disease'
PANCREATIC cancer is the 10th most common cancer in the UK. It's been dubbed as a "silent disease" because of the difficulty to spot symptoms in the early stages. This can make it difficult to identify, but there are certain signs to look out for including one when you go to the toilet. (Source: Daily Express - Health)
Source: Daily Express - Health - October 16, 2021 Category: Consumer Health News Source Type: news

'Do not ignore!': Son highlights early symptom of pancreatic cancer after dad dies
A SON in the throes of grief has made a documentary urging people to recognise the early warning signs of pancreatic cancer after his dad, Paul Kennedy, died of the disease last year. Issuing an important public health message, Paul's son Daniel drew attention to his dad's first symptom. (Source: Daily Express - Health)
Source: Daily Express - Health - October 15, 2021 Category: Consumer Health News Source Type: news

PET tracer shows promise for diagnosing breast cancer
An experimental radiotracer based on gallium-68 can help identify primary an...Read more on AuntMinnie.comRelated Reading: Sofie submits IND application for pancreatic PET agent New PET radiotracer more effective at detecting cancer PET detects activity in early atherosclerosis Animal study suggests Ga-68 PET FAPI can detect lung fibrosis PET/CT with Ga-68 tracer better for cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2021 Category: Radiology Source Type: news

PET tracer shows promise diagnosing breast cancer
An experimental radiotracer based on gallium-68 can help identify primary an...Read more on AuntMinnie.comRelated Reading: Sofie submits IND application for pancreatic PET agent New PET radiotracer more effective at detecting cancer PET detects activity in early atherosclerosis Animal study suggests Ga-68 PET FAPI can detect lung fibrosis PET/CT with Ga-68 tracer better for cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2021 Category: Radiology Source Type: news

Sofie submits IND application for pancreatic PET agent
Molecular imaging developer Sofie Biosciences has submitted an investigationa...Read more on AuntMinnie.comRelated Reading: iTheranostics, Novartis ink FAP-targeted drug development agreement Sofie, Lantheus ink deal for prostate cancer imaging agent Jubilant inks deal to invest $25M in Sofie Sofie signs deal with ABX for cGMP compliance Sofie signs exclusive license for new FAPI radiotracers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2021 Category: Radiology Source Type: news

Pancreatic cancer: Malaise is a common early symptom of the disease – what is it?
PANCREATIC cancer has the lowest survival of all common cancers stressing the importance of being aware of the early warning symptoms including malaise. (Source: Daily Express - Health)
Source: Daily Express - Health - October 8, 2021 Category: Consumer Health News Source Type: news

Unexpected Thrombocytosis Could Flag Occult Cancer Unexpected Thrombocytosis Could Flag Occult Cancer
Thrombocytosis that shows up in a routine blood test increases the risk for an imminent diagnosis of several typically'silent'cancers, such as pancreatic, ovarian, and cervical cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pancreatic cancer symptoms: Signs of the disease to look out for when you go to the toilet
PANCREATIC cancer may not have any symptoms, or they might be hard to spot. Nonetheless, there are some signs you can look out for when you go to the toilet. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2021 Category: Consumer Health News Source Type: news

Where Do Pancreatic Neuroendocrine Tumors Metastasize?
Title: Where Do Pancreatic Neuroendocrine Tumors Metastasize?Category: Diseases and ConditionsCreated: 9/23/2021 12:00:00 AMLast Editorial Review: 9/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 23, 2021 Category: Cancer & Oncology Source Type: news

What Is the Most Common Pancreatic Neuroendocrine Tumor?
Title: What Is the Most Common Pancreatic Neuroendocrine Tumor?Category: Diseases and ConditionsCreated: 9/23/2021 12:00:00 AMLast Editorial Review: 9/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 23, 2021 Category: Cancer & Oncology Source Type: news

Is a Neuroendocrine Tumor the Same as Pancreatic Cancer?
Title: Is a Neuroendocrine Tumor the Same as Pancreatic Cancer?Category: Diseases and ConditionsCreated: 9/23/2021 12:00:00 AMLast Editorial Review: 9/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 23, 2021 Category: Cancer & Oncology Source Type: news

How Does Pancreatic Neuroendocrine Tumor Affect the Body?
Title: How Does Pancreatic Neuroendocrine Tumor Affect the Body?Category: Diseases and ConditionsCreated: 9/23/2021 12:00:00 AMLast Editorial Review: 9/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 23, 2021 Category: Cancer & Oncology Source Type: news

How Is Pancreatic Neuroendocrine Tumor Diagnosed?
Title: How Is Pancreatic Neuroendocrine Tumor Diagnosed?Category: Procedures and TestsCreated: 9/22/2021 12:00:00 AMLast Editorial Review: 9/22/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 22, 2021 Category: Cancer & Oncology Source Type: news

Is Chemo Worth It for Pancreatic Cancer?
Title: Is Chemo Worth It for Pancreatic Cancer?Category: Diseases and ConditionsCreated: 9/21/2021 12:00:00 AMLast Editorial Review: 9/21/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 21, 2021 Category: Cancer & Oncology Source Type: news

Cell therapy partnership between Bay Area biotechs offers hope to cancer patients
Imagine a world in which physicians can confidently cure cancer. Two Bay Area life sciences companies are working together to make this vision a reality. Atara Biotherapeutics Inc., founded in 2012, is developing a pipeline of cell therapies to treat various types of cancer and autoimmune diseases. Bayer is licensing Atara’s cutting-edge cell therapies that t arget certain types of aggressive tumors including mesothelioma, pancreatic, ovarian and non-small-cell lung cancer. “With cancer therapies,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 16, 2021 Category: Pharmaceuticals Authors: Lauren Lawley Head Source Type: news

Will new DNA blood test revolutionise cancer diagnosis?
Specialist district nurse practitioner Temi Adeloye, 53, lives in Peckham, South London. Her mother passed away in 2009 aged 66 from pancreatic cancer, which has no visible signs in the early stages. (Source: the Mail online | Health)
Source: the Mail online | Health - September 13, 2021 Category: Consumer Health News Source Type: news

Wonder blood test can find 50 cancer types BEFORE symptoms - NHS trials start TODAY
NHS doctors today began using a "revolutionary" blood test to spot more than 50 cancers earlier. The Galleri process is particularly good at detecting hard-to-diagnose tumours including bowel and pancreatic cancers. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer: Change in body temperature? The hidden warning sign to spot
PANCREATIC cancer symptoms are known to be vague and sometimes non-existent hence the danger of the disease in that most people are unaware they have it until it has advanced. A change in body temperature or a prolonged fever could be a major indicator. (Source: Daily Express - Health)
Source: Daily Express - Health - September 6, 2021 Category: Consumer Health News Source Type: news

November 4, 2021: Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) Meeting Announcement - 11/04/2021 - 11/04/2021
November 4, 2021: Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) Meeting Announcement (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

The good side of CXCL10 in cancer
CXCL10 signaling prevents, rather than promotes, progression of premalignant pancreatic neoplasia. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - August 24, 2021 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

PET radiomics predict relapse in lymphoma patients
There's more to F-18 FDG PET than meets the eye -- especially if radiomics feature...Read more on AuntMinnie.comRelated Reading: PET recommended over bone scintigraphy in pediatric sarcoma PET/CT predicts survival in pancreatic cancer patients PET/CT may predict outcomes in lung cancer surgery PET is useful modality in patients with lymphomas Routine PET field-of-view enough for pediatric lymphoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 23, 2021 Category: Radiology Source Type: news

Far Too Few People of Color in U.S. Pancreatic Cancer Trials
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 18, 2021 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Research, News, Source Type: news

Far Too Few People of Color in U.S. Pancreatic Cancer Trials
WEDNESDAY, Aug. 18, 2021 -- Racial and ethnic minorities in the United States are severely underrepresented in clinical trials testing cutting-edge treatments for pancreatic cancer, researchers say. " There are a ton of obstacles to get these... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 18, 2021 Category: General Medicine Source Type: news

Minorities, Women Underrepresented in Pancreatic Cancer Trials
84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 17, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Pharmacy, Journal, Source Type: news

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
PALB2 is not as well known as BRCA, but mutations of the gene can raise a woman ’s risk for breast cancer almost as much. (Source: NYT Health)
Source: NYT Health - August 17, 2021 Category: Consumer Health News Authors: Susan Berger Tags: your-feed-science Breast Cancer Genetics and Heredity Tests (Medical) Pancreatic Cancer Ovarian Cancer Women and Girls American College of Medical Genetics your-feed-healthcare Source Type: news

Minorities, Women Underrepresented in Pancreatic Cancer Trials
TUESDAY, Aug. 17, 2021 -- Non-White, Hispanic, and female patients with pancreatic cancer are underrepresented in clinical trials, according to a study published online Aug. 17 in Gastroenterology. Kelly M. Herremans, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2021 Category: Pharmaceuticals Source Type: news

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
PALB2 is not as well known as BRCA, but mutations of the gene can raise a woman ’s risk for breast cancer almost as much. (Source: NYT Health)
Source: NYT Health - August 17, 2021 Category: Consumer Health News Authors: Susan Berger Tags: your-feed-science Breast Cancer Genetics and Heredity Tests (Medical) Pancreatic Cancer Ovarian Cancer Women and Girls American College of Medical Genetics your-feed-healthcare Source Type: news

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-184 in the Treatment of Pancreatic Cancer
DALLAS, Aug. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, a... Biopharmaceuticals, Oncology, FDA Lantern Pharma, RADR, LP-184, Pancreatic Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 11, 2021 Category: Pharmaceuticals Source Type: news

FDG-PET/CT predicts severity of COVID-19 infection
FDG PET/CT imaging in patients diagnosed with COVID-19 is associated with ...Read more on AuntMinnie.comRelated Reading: PET/CT predicts survival in pancreatic cancer patients CMS revokes PET infection, inflammation imaging barrier PET/CT may predict outcomes in lung cancer surgery PET/CT shows promise predicting outcomes in head, neck cancer FDG-PET identifies biomarkers in dementia with Lewy bodies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 11, 2021 Category: Radiology Source Type: news

PET/CT predicts survival in pancreatic cancer patients
PET/CT imaging can help predict survival early after the start of chemotherap...Read more on AuntMinnie.comRelated Reading: PET/CT may predict outcomes in lung cancer surgery New PET tracer detects Alzheimer's disease pathology PET/CT shows promise predicting outcomes in head, neck cancer New PET tracer targets iron in cancer FDG-PET identifies biomarkers in dementia with Lewy bodies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 9, 2021 Category: Radiology Source Type: news

Longtime Florida State football coach Bobby Bowden dies at 91
Longtime Florida State coach Bobby Bowden has died at 91. He was diagnosed with pancreatic cancer in July. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2021 Category: Consumer Health News Source Type: news

Eliminating RNA-binding protein improves survival in aggressive leukemia
Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer ’s development and significantly increase the likelihood of survival, according to a study in mice led by scientists at theUCLA Jonsson Comprehensive Cancer Center.The research,published today in the journal Leukemia, could aid in the development of targeted therapies for cancers that have high levels of the RNA-binding protein IGF2BP3 — especially acute lymphoblastic and myeloid leukemias that are characterized by chromosomal rearrangements in the mixed lineage leukemia (MLL) gene.In these ML...
Source: UCLA Newsroom: Health Sciences - July 29, 2021 Category: Universities & Medical Training Source Type: news

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Dinah Murray obituary
Champion of autistic people who explored the attention that they devote to a leading interestDinah Murray, who has died aged 75 of pancreatic cancer, was a key figure in autism studies, and an indefatigable advocate for autistic people for three decades. Her acute insight lay in the importance of attention and interests to an understanding of the condition.On the autistic spectrum herself andfascinated with language and the mind, in 1991 Murray read Uta Frith ’s book Autism: Explaining the Enigma. She had aeureka moment when it spoke of an autistic person ’s attention “going to their leading interest&rdqu...
Source: Guardian Unlimited Science - July 25, 2021 Category: Science Authors: Penny Warren Tags: Autism Society Psychology Science University of London Source Type: news

New Drug Combination Shows Promise for Peritoneal Mesothelioma
Researchers at MD Anderson Cancer Center in Houston have uncovered a new, promising treatment option for patients with peritoneal mesothelioma, potentially filling a gaping void that exists today. The immunotherapy drug combination of Tecentriq and Avastin, known generically as atezolizumab and bevacizumab, respectively, showed unusual efficacy in a recent study of 20 patients with this rare cancer. Although some patients have previously found significant success and extended survival with the cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combination, or HIPEC, those with unresectable disease ha...
Source: Asbestos and Mesothelioma News - July 21, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Immune cells assemble - boosting the effects of chemotherapy in pancreatic cancer
(Queen Mary University of London) A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas
(Society of Nuclear Medicine and Molecular Imaging) For patients with pancreatic ductal adenocarcinomas (PDAC), molecular imaging can improve staging and clinical management of the disease, according to research published in the June issue of The Journal of Nuclear Medicine. In a retrospective study of PDAC patients, the addition of PET/CT imaging with 68Ga-FAPI led to restaging of disease in more than half of the patients, most notably in those with local recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2021 Category: Cancer & Oncology Source Type: news

Blood test to spot pancreatic cancer could be available within months
The first blood test for early diagnosis of the hard-to-spot disease, it could be available within months. Pancreatic cancer has the lowest survival rate of the common cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2021 Category: Consumer Health News Source Type: news

Oncotarget: General anesthesia for pancreatic cancer surgery
(Impact Journals LLC) The major finding of this Oncotarget study was perioperative tryptophan depletion and increased taurine synthesis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2021 Category: Cancer & Oncology Source Type: news

MasSpec Pen shows promise in pancreatic cancer surgery
(University of Texas at Austin) A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery. The device is shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples. At about 15 seconds per analysis, the method is more than 100 times as fast as the current gold standard diagnostic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2021 Category: Cancer & Oncology Source Type: news

Scientists reveal a new therapeutic vulnerability in pancreatic cancer
(Columbia University Irving Medical Center) Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

Online symposium addresses issues of cancer research and palliative care
(Leopoldina) Why does pancreatic cancer develop, what new therapies might be effective against metastasis formation, and what is to be considered in palliative care? Members of the German National Academy of Sciences Leopoldina will address these questions at the virtual symposium of Class III Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

Study identifies biomarker that could help to diagnose pancreatic cancer
(Queen Mary University of London) Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news

Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
(Impact Journals LLC) Support recently reported findings of clinical benefit when relacorilant is added to paclitaxel-containing therapy in patients with ovarian and pancreatic cancers and provide a new rationale for combining relacorilant with additional cytotoxic agents. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news

How pancreatic cancer cells dodge drug treatments
(Cold Spring Harbor Laboratory) Pancreatic cancer cells typically rely on a mutant version of the KRAS protein to proliferate. These cancer cells can also survive losing KRAS by activating alternative growth pathways. CSHL scientists discovered a new interaction between mutant KRAS and a protein complex called RSK1/NF1 that may be the source of this adaptive resistance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news

Pancreatic cancer symptoms: Survivor Olivia Williams shares 'bizarre' symptom to spot
OLIVIA WILLIAMS starred in An Education, The Sixth Sense and Rushmore, yet the award-winning actress's most fulfilling role is that of Pancreatic Cancer UK ambassador. (Source: Daily Express - Health)
Source: Daily Express - Health - June 17, 2021 Category: Consumer Health News Source Type: news

Targeted drug found effective in thwarting pancreatic tumors
(Virginia Commonwealth University) Through a pre-clinical study conducted in his former role at Moffitt Cancer Center and published in Clinical Cancer Research, Said Sebti, Ph.D., associate director for basic research at VCU Massey Cancer Center, identified a novel drug that effectively thwarts pancreatic tumors that are addicted to the cancer-causing mutant KRAS gene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

Drug commonly used as antidepressant helps fight cancer in mice
A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain ’s “happiness hormone.”A new study by UCLA researchers suggests that those drugs, commonly known as MAOIs, might have another health benefit: helping the immune system attack cancer. Their findings are reported in two papers, which are published in the journals Science Immunology and Nature Communications.“MAOIs had not been linked to the immune system’s response to cancer before,” saidLili Yang, senior author of the study and a m...
Source: UCLA Newsroom: Health Sciences - June 10, 2021 Category: Universities & Medical Training Source Type: news

First AI-based tool for predicting genomic subtypes of pancreatic cancer from histology slides
(Owkin, Inc.) AP-HP Greater Paris University Hospitals and Owkin announced the recent results of their ongoing strategic collaboration at ASCO 2021. Their abstract demonstrates the first AI-based tool for predicting genomic subtypes of pancreatic cancer (PDAC) developed from machine learning applied to histology slides. The tool, a trained and validated AI model, is usable in clinical practice worldwide and opens the possibility of patient molecular stratification in routine care and for clinical trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 10, 2021 Category: Cancer & Oncology Source Type: news

Cancer symptoms: What does your poo smell like? Major warning sign of pancreatic cancer
CANCER symptoms must be acted upon as soon as they arise because early intervention can help stem the spread to other areas. The smell of your poo can signal pancreatic cancer - does yours smell like this? (Source: Daily Express - Health)
Source: Daily Express - Health - June 9, 2021 Category: Consumer Health News Source Type: news